Cyberonics says FDA warning letter case now closed
This article was originally published in Clinica
Executive Summary
Cyberonics, the maker of an implantable vagus nerve stimulation system to treat epilepsy, says the FDA has closed its warning letter case. The company received a warning letter on December 22 after failing to address satisfactorily issues identified in an inspection by the agency's Dallas district office.